DocuSign (NASDAQ:DOCU - Get Free Report) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating in a report issued on Friday, Marketbeat reports. The brokerage presently has a $80.00 price objective on the stock, up from their prior price objective of $67.00. Wells Fargo & Company's price target indicates a potential upside of 8.02% from the stock's previous close.
Several other brokerages have also weighed in on DOCU. HSBC upgraded DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price target for the company in a research note on Friday, April 11th. Wedbush dropped their price target on shares of DocuSign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday. Royal Bank of Canada reissued a "sector perform" rating and issued a $90.00 price target on shares of DocuSign in a report on Friday, March 14th. Jefferies Financial Group decreased their price objective on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, March 31st. Finally, JPMorgan Chase & Co. dropped their target price on shares of DocuSign from $81.00 to $77.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Twelve research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, DocuSign currently has an average rating of "Hold" and an average target price of $89.77.
Get Our Latest Report on DOCU
DocuSign Trading Down 2.6%
DocuSign stock traded down $1.95 during mid-day trading on Friday, hitting $74.06. The company had a trading volume of 3,322,576 shares, compared to its average volume of 2,849,305. The company has a market capitalization of $14.96 billion, a price-to-earnings ratio of 15.27, a P/E/G ratio of 6.94 and a beta of 1.14. DocuSign has a 12-month low of $48.80 and a 12-month high of $107.86. The company's fifty day moving average is $82.14 and its 200-day moving average is $86.09.
DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.09. The firm had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business's revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.82 EPS. As a group, sell-side analysts expect that DocuSign will post 1.17 EPS for the current fiscal year.
DocuSign announced that its Board of Directors has initiated a share buyback plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 6.6% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued.
Insider Buying and Selling
In related news, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares of the company's stock, valued at approximately $722,880.70. This trade represents a 6.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the completion of the sale, the chief financial officer now owns 93,960 shares in the company, valued at approximately $7,817,472. This trade represents a 14.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. Insiders own 1.01% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the stock. Stratos Wealth Partners LTD. acquired a new stake in DocuSign in the 4th quarter valued at approximately $224,000. Kingsview Wealth Management LLC purchased a new position in shares of DocuSign during the fourth quarter worth $226,000. Van ECK Associates Corp acquired a new stake in shares of DocuSign in the fourth quarter valued at $4,664,000. Asset Management One Co. Ltd. raised its holdings in shares of DocuSign by 3.5% in the 4th quarter. Asset Management One Co. Ltd. now owns 75,662 shares of the company's stock valued at $7,037,000 after buying an additional 2,565 shares during the period. Finally, New York State Teachers Retirement System lifted its stake in DocuSign by 894.3% during the 4th quarter. New York State Teachers Retirement System now owns 185,850 shares of the company's stock worth $16,715,000 after acquiring an additional 167,158 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.
About DocuSign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.